Clinical Trial Update: Evaluation of 200 mg of Rituximab Every 6 Months as Maintenance Treatment of Rituximab-treated Patients With Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial is evaluating maintenance therapy with Rituximab 200 mg every 6 months in patients with rheumatoid arthritis who have previously rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Rheumatoid Arthritis (RA), Rituximab (RTx) | Phase 4 | Status: RECRUITING